Evaluation of a Multimodal Day Hospital for the Overall Management of Patients With Chronic Inflammatory Bowel Diseases (IBD)
Observational · No treatment assigned · 1 site · Assistance Publique - Hôpitaux de Paris
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Inflammatory Bowel Disease (IBD), Crohn Disease and Ulcerative Colitis (Disorder). This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 and older
- Any sex
Some of the main requirements, copied from the record:
- Patient diagnosed with ulcerative colitis and Crohn's disease for more than 3 months, with a confirmed diagnosis according to European guidelines, being followed in the gastroenterology department at Saint Antoine Hospital.
- Aged over 18 years.
- Undergoing a multimodal day hospital visit, regardless of the scheduled intervention in the gastroenterology department at Saint Antoine Hospital.
Plus 1 more requirement(s). There are also 3 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 240 participants are expected to take part.
- Start date: 2025-09 (planned).
- Main results expected around 2026-02 (estimate from the record).
- 1 study site listed in France.
Main thing being measured
- Proportion of patients with a change in their skills at one month or a modification in the management of their disease (1 month)
In the researchers’ words
Inflammatory bowel diseases (IBD) are long-term conditions affecting more than 250,000 people in France. They typically begin in young adults and are characterized by flare-ups interspersed with periods of remission.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Not yet recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Inflammatory Bowel Disease (IBD); Crohn Disease; Ulcerative Colitis (Disorder) |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris |
| Enrollment | 240 (estimated) |
| Start date | 2025-09 |
| Primary completion (est.) | 2026-02 |
| First posted | 2025-09-11 |
| Last updated | 2025-09-11 |
| Official title | Evaluation of a Multimodal Day Hospital for the Overall Management of Patients With Chronic Inflammatory Bowel Diseases (IBD) |
| ClinicalTrials.gov ID | NCT07167186 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: * Patient diagnosed with ulcerative colitis and Crohn's disease for more than 3 months, with a confirmed diagnosis according to European guidelines, being followed in the gastroenterology department at Saint Antoine Hospital. * Aged over 18 years. * Undergoing a multimodal day hospital visit, regardless of the scheduled intervention in the gastroenterology department at Saint Antoine Hospital. * Not opposed to participating in the research. Exclusion Criteria: * Protective measure in place. * Patient who has previously participated in an equivalent day hospital program. * Pregnant woman.
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Service de gastroentérologie Hôpital Saint Antoine | Paris | France |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.